Concepedia

X. Li

XL

Statistics

Publications

2

Citations

149

H-Index

2

Active since

2016

Affiliations

Eli Lilly (United States)(Current)

X. Li is an author at Eli Lilly (United States) specializing in medicine, psychopharmacology, and pharmacology of glutamate receptors.

Publications per year

2016–2017

2

Publications

2

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits

J M Witkin, James A. Monn, Darryle D. Schoepp et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 106 citations

, , +17

Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.

Jeffrey M. Witkin, S.N. Mitchell, Keith A. Wafford et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 43 citations

, , +17

1–2 of 2